| Product Name | Vedroprevir - API |
| Product Code | DA-V063-a |
| Chemical name | Vedroprevir |
| Synonyms | (1R,2R)-1-((2S,4R)-1-((2S)-2-(((((1R,5S)-bicyclo[3.1.0]hexan-3-yl)oxy)carbonyl)amino)-3,3-dimethylbutanoyl)-4-((8-chloro-2-(2-(isopropylamino)thiazol-4-yl)-7-(2-morpholinoethoxy)quinolin-4-yl)oxy)pyrrolidine-2-carboxamido)-2-ethylcyclopropane-1-carboxylic acid; |
| Impurity | NA |
| CAS Number | 1098189-15-1 |
| Alternate CAS # | NA |
| Molecular form | C45H60ClN7O9S |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 910.53 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals |
| Boiling Point | NA |
| Applications | Vedroprevir is a pharmaceutical drug that is used in the treatment of hepatitis C virus in patients with HCV genotype 1 infection. It inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | |
| Documents (MSDS) | No Data Available |
| Keywords |
